–
Merck’s Covid-19 drug, Molnupiravir, will be tested in Indonesia.
–
GridHEALTH.id – Antivirus pill Molnupiravir reportedly will be tested by Indonesia.
This was conveyed by the Minister of Health (Menkes) Budi Gunadi Sadikin in a virtual press conference on PPKM Extension, Monday (4/10/2021).
According to him, the Ministry of Health continues to work closely with BPOM and various vertical hospitals to conduct reviews and clinical trials of drugs that have the potential to treat Covid-19 in the country.
Starting from drugs that are monoclonal antibodies (artificial proteins that mimic the ability of the immune system to fight harmful pathogens) such as drugs made by producers of ely lilies, renegeron and celltrion.
Until drugs that are antiviral like pills Molnupiravir made by the United States company Merck
“So we have the drugs approach the manufacturer,” said Budi, quoted from tribunnews.com (4/10/2021).
Also Read: Hopes and Facts Molnupiravir, Oral Antiviral Treatment for COVID-19
PROMOTED CONTENT
Featured Videos
– .
